Alvida Yatra Tejashwi Yadavs Jibe Ahead Of Nitish Kumars Pragati Yatra
ASMB Stock | USD 11.15 0.03 0.27% |
About 65% of Assembly Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Assembly Biosciences suggests that many traders are alarmed. The current market sentiment, together with Assembly Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Assembly Biosciences stock news signals to limit their universe of possible portfolio assets.
Assembly |
Days ahead of Bihar CM Nitish Kumars Pragati Yatra which will begin on December 23, Tejashwi Yadav, the Leader of the Opposition in the Assembly criticised the JD-U leader while calling the CMs proposed programme an Alvida Yatra .
Read at ndtv.com
![]() |
Assembly Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Assembly Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Assembly Biosciences Fundamental Analysis
We analyze Assembly Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Assembly Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Assembly Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Assembly Biosciences is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Assembly Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Assembly Biosciences stock to make a market-neutral strategy. Peer analysis of Assembly Biosciences could also be used in its relative valuation, which is a method of valuing Assembly Biosciences by comparing valuation metrics with similar companies.
Peers
Assembly Biosciences Related Equities
CTMX | CytomX Therapeutics | 1.52 | ||||
ACHL | Achilles Therapeutics | 1.46 | ||||
NXTC | NextCure | 0.68 | ||||
SPRO | Spero Therapeutics | 3.85 | ||||
NUVB | Nuvation Bio | 6.93 | ||||
TIL | Instil Bio | 9.89 |
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |